Peeling Back The Layers: Exploring AbbVie Through Analyst Insights
Peeling Back The Layers: Exploring AbbVie Through Analyst Insights
透过分析师洞察艾伯维公司内部结构
Analysts' ratings for AbbVie (NYSE:ABBV) over the last quarter vary from bullish to bearish, as provided by 10 analysts.
10位分析师提供的分析师对艾伯维（纽约证券交易所代码：ABBV）在上个季度的评级从看涨到看跌不等。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表简要概述了他们最近的评级，重点介绍了过去30天中情绪的变化，并将其与前几个月进行了比较。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $194.2, with a high estimate of $214.00 and a low estimate of $180.00. Marking an increase of 1.15%, the current average surpasses the previous average price target of $192.00.
分析师对12个月目标股价的评估提供了更多见解，显示平均目标价为194.2美元，最高估计为214.00美元，最低估计为180.00美元。当前的平均价格上涨了1.15％，超过了之前的平均目标股价192.00美元。
Deciphering Analyst Ratings: An In-Depth Analysis
解密分析师评级：深度分析
The standing of AbbVie among financial experts is revealed through...
通过对近期分析师行为...
登录免费看全文
登录/注册